---
title: "Active Cardiovascular Trials at Amavita Research"
url: https://md.amavitaresearch.com/trials
canonical: https://www.amavitaresearch.com/trials
schema_type: CollectionPage
last_updated: 2026-05-12
---

# Active Cardiovascular Trials at Amavita Research

Amavita Research enrolls patients in cardiovascular clinical trials across multiple therapeutic areas. Visit https://www.amavitaresearch.com/trials for the current active list with inclusion criteria.

## Active trial portfolio (representative)

- **ZENITH** — Zilebesiran (Alnylam, ALN-AGT01-008) — Phase 3 — Treatment-Resistant Hypertension
- **Librexia ACS** (Pfizer, C4921003) — Phase 3 — Acute Coronary Syndrome
- **JK07** (JK07201) — Phase 2 — Heart Failure
- **IV Ferric Derisomaltose** (Pharmacosmos) — Phase 3 — Iron-Deficient Heart Failure
- **VS-041** (VASA Therapeutics) — Phase 1 — HFpEF (Heart Failure with preserved Ejection Fraction)
- **PF-07328948** (Pfizer) — Phase 2 — HFpEF
- **Golazo® GREAT** (Cardiovascular Systems) — Phase 3 — Peripheral Artery Disease

## How to join

- Browse current trials and eligibility criteria: https://www.amavitaresearch.com/trials
- Call a study coordinator: (786) 703-5941
- Email: research@amavita.health
- See the patient FAQ for what to expect: https://www.amavitaresearch.com/faq-patients